MYnd Analytics Partners with Sanford Health to Provide Telepsychiatry Services Supporting Outpatient Primary Care Practices
MISSION VIEJO, Calif., Sept. 13, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and data analytics/augmented intelligence, today announced that its wholly owned subsidiary, Arcadian Telepsychiatry Services LLC, has partnered with Sanford Health to provide telebehavioral health and telepsychiatry services through Arcadian’s provider network for Sanford Health’s network of outpatient primary care practices.
Sanford Health is an integrated health system headquartered in the Dakotas, and is one of the largest not-for-profit health care systems in the nation with 44 hospitals and 300 clinics in nine states and nine countries. The program is expected to initially launch with primary care practices in Iowa and South Dakota followed by Minnesota and North Dakota.
Telebehavioral health and telepsychiatry involve the use of video conferencing equipment to conduct real-time mental health consultations between a clinician and a patient. The program is designed to improve access to care for patients, especially those in underserved markets, as well as reduce waiting times. The program is also designed to reduce interruptions in the patients’ daily lives, helping patients better manage their symptoms and reduce lost time from work.
“Telehealth services are increasingly critical to serving patients across Sanford Health’s footprint,” said Allison Suttle, M.D., Sanford Health chief medical officer. “To be able to offer telebehavioral health and telepsychiatry services will help patients access those services with limited disruptions to their daily activities.”
Robert Plotkin, CEO and Founder of Arcadian, stated, “We look forward to working closely with Sanford Health and rolling out our telebehavioral health services across their network. These services are ideally suited for Sanford’s affiliated outpatient primary care practices, many of which are located within rural and suburban markets. Over eighty-nine million Americans live in federally designated Mental Health Professional Shortage Areas and two-thirds of US primary care physicians report not having adequate access to psychiatric care for their patients. Through this offering, we can now offer individuals living in underserved areas with improved access to care, helping primary care physicians move towards a true collaborative care model with psychiatrists.”
About Sanford Health
Sanford Health is one of the largest health care systems in the nation, with 44 hospitals and nearly 300 clinics in nine states and nine countries. Headquartered in Sioux Falls, South Dakota, and serving the Upper Midwest, with nearly 1,400 physicians, Sanford Health is dedicated to several initiatives, including global children’s clinics, genomic medicine and specialized centers researching cures for type 1 diabetes, breast cancer and other diseases. Sanford Health has 28,000 employees, making it the largest employer in the Dakotas. Nearly $1 billion in gifts from philanthropist Denny Sanford over the past decade have transformed how Sanford Health can improve the human condition. For information, visit sanfordhealth.org.
About MYnd Analytics
MYnd Analytics, Inc. (www.myndanalytics.com) is a predictive analytics company that has developed a decision support tool to help physicians reduce trial and error treatment in mental health and provide more personalized care to patients. The Company’s Psychiatric EEG Evaluation Registry, or PEER Online, is a registry and reporting platform that allows medical professionals to exchange treatment outcome data for patients referenced to objective neurophysiology data obtained through a standard electroencephalogram (EEG). Based on the Company’s original physician-developed database, there are now more than 39,000 outcomes for over 11,000 unique patients in the PEER registry. The goal of PEER Online is to provide objective, personalized data to assist physicians in the selection of appropriate medications. To read more about the benefits of this patented technology for patients, physicians and payers, please visit: www.myndanalytics.com.
MYnd also operates its wholly owned subsidiarity Arcadian Telepsychiatry Services, LLC which manages a suite of services including telepsychiatry, teletherapy, digital patient screening, curbside consultation, on-demand services, and scheduled encounters for all age groups. Arcadian utilizes patient engagement and re-engagement strategies so that care is effectively completed, helping to comfortably move inpatient care to outpatient, assisting patients in readjusting to their life routine, as well as reducing wait times for mental health treatment. Arcadian’s customer base includes major health plans, health systems, and community-based organizations.
Except for the historical information contained herein, the matters discussed are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements involve risks and uncertainties, such as statements regarding market developments, new products and growth strategies, Arcadian's ability to reduce patient suffering through increased access to care, Arcadian's ability to use MYnd’s data analytics capabilities to successfully reduce trial and error prescribing, advantages offered by telemedicine, the ability of MYnd’s and Arcadian's products to successfully target objectivity and increased efficiency in the treatment of depression and other mental health and psychiatric illnesses, as well as those risks and uncertainties set forth in MYnd's filings with the Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from any forward-looking statements made herein.
Crescendo Communications, LLC
Tel: +1 (212) 671-1020
Released September 13, 2018